Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Treatment Options
100%
Consensus Recommendations
100%
Mycosis Fungoides
100%
EORTC
100%
Clinical Course
33%
Clinical Practice
33%
Epidemiology
33%
Tumor
33%
Pegylated Interferon
33%
Disease Treatment
33%
Major Change
33%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
33%
Patient Care
33%
Disease Stage
33%
Advanced Disease
33%
Older Patients
33%
Interferon-α (IFN-α)
33%
Long-term Remission
33%
Recombinant
33%
Impaired Quality of Life
33%
Duration of Response
33%
Patient Prognosis
33%
Normal Life Expectancy
33%
Well-founded
33%
Appropriate Management
33%
Supportive Therapy
33%
Brentuximab Vedotin
33%
Selected Subset
33%
Chlormethine
33%
Mogamulizumab
33%
Cutaneous Lymphoma
33%
Skin-directed Therapy
33%
Medicine and Dentistry
Mycosis fungoides
100%
Diseases
100%
Treatment Option
100%
Disease Course
33%
Quality of Life
33%
Cohort Effect
33%
Peginterferon
33%
Life Expectancy
33%
Hope
33%
Morbidity
33%
Interferon
33%
Allogeneic Stem Cell Transplantation
33%
Cutaneous Lymphoma
33%
Tumor
33%
Brentuximab Vedotin
33%
Chlormethine
33%
Mogamulizumab
33%